{
  "contract_version": "supplier-contract-v0.1",
  "project": "col-901831",
  "supplier_group_id": "WUXI_YUSHOU",
  "generated_at": "2026-04-17T02:24:13.580Z",
  "model": "gpt-4.1-mini",
  "provider_stack": [
    "openai"
  ],
  "narratives": {
    "positioning_summary": "WUXI YUSHOU 是 HS 9018312000 注射器品类中份额 2.05% 的 Tier A 供应商，活跃于 2013–2015 年。",
    "buyer_strategy": "海外买家结构高度集中，Top1 买家 LIFE CARE SOLUTIONS S.A.S. 占比 54.9%，Top2 买家 IMPOMEDICAS DE COLOMBIA LTDA 占比 38.0%，攻守难度中等偏易。",
    "pricing_read": "其加权均价 $0.0273/unit 比市场均价 $0.0434/unit 低 37.0%，主战场在 $0.0248–$0.0282 档位，从 $0.0282–$0.0322 档位切入可避开其低价内卷。",
    "trend_read": "其 CAGR 为 -66.1%，末年份额仅 12%，海外买家净减 2 家，处于退场阶段。",
    "competitive_angles": {
      "strengths": [
        "Top1 买家 LIFE CARE SOLUTIONS S.A.S. 依赖度高达 54.9%。",
        "出货批次达 46 批，历史交易记录完整。",
        "付款方式灵活，直接电汇占比 90%。"
      ],
      "weaknesses": [
        "价格显著低于市场均价，利润空间被压缩。",
        "Top2 买家 IMPOMEDICAS DE COLOMBIA LTDA 已接盘方为 HENGXIANG。",
        "CAGR 为 -66.1%，业务规模持续萎缩。"
      ],
      "how_to_attack": "优先接触流失的 IMPOMEDICAS DE COLOMBIA LTDA 和份额下降的 LIFE CARE SOLUTIONS S.A.S.。报价切入 $0.0282–$0.0322 档位，略高于其主战场 $0.0248–$0.0282。利用其 67% 货物走 Buenaventura 港口的习惯，承诺同等港口交付以消除物流顾虑。"
    },
    "buyer_opportunities": [
      {
        "buyer": "LIFE CARE SOLUTIONS S.A.S.",
        "angle": "Top依赖",
        "action": "本周联系该买家，报价 $0.0282–$0.0322，强调比其当前均价 $0.0273 更具性价比但质量更稳。"
      },
      {
        "buyer": "IMPOMEDICAS DE COLOMBIA LTDA",
        "angle": "流失",
        "action": "本周直接联系该买家，告知其原供应商份额已降至 38.0%，提供 $0.0282–$0.0322 价格段样品。"
      },
      {
        "buyer": "WELL MEDICINE PRODUCTS SAS",
        "angle": "Top依赖",
        "action": "本周联系该买家，利用其仅 2 批交易的小体量优势，报价 $0.0282–$0.0322 快速切入。"
      }
    ]
  }
}